A prospective, double-blind, randomized controlled trial of the angiotensin-converting enzyme inhibitor Ramipril In Aortic Stenosis (RIAS trial)

AIMS: Angiotensin-converting enzyme (ACE) inhibitors improve left ventricular (LV) remodelling and outcome in heart failure and hypertensive heart disease. They may be similarly beneficial in patients with aortic stenosis (AS), but historical safety concerns have limited their use, and no prospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Bull, Sacha, Loudon, Margaret, Francis, Jane M., Joseph, Jubin, Gerry, Stephen, Karamitsos, Theodoros D., Prendergast, Bernard D., Banning, Adrian P., Neubauer, Stefan, Myerson, Saul G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505792/
https://www.ncbi.nlm.nih.gov/pubmed/25796267
http://dx.doi.org/10.1093/ehjci/jev043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505792/
https://www.ncbi.nlm.nih.gov/pubmed/25796267
http://dx.doi.org/10.1093/ehjci/jev043

Ejemplares similares